Vox Markets interview Tim McCarthy, Chairman of ImmuPharma (IMM) – July 2019

3rd July 2019 - 4:41 pm

Tim McCarthy, Chairman of ImmuPharma (IMM) talks to Vox Markets on the recent £2.66m subscription with Lanstead and the Lupuzor™ 6 month extension study

Share this article